Atrial Fibrillation Management

Introduction to Atrial Fibrillation

Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation, leading to irregular ventricular response and increased risk of stroke and mortality, as stated by the European Heart Journal 1
The condition results in loss of effective atrial contraction, leading to reduced cardiac output 1

Structural remodeling in AF includes proliferation of fibroblasts, enhanced connective tissue deposition, and fibrosis, as reported by the European Heart Journal 2
Electrical remodeling in AF involves shortening of atrial effective refractory period, including down-regulation of L-type Ca²⁺ inward current and up-regulation of inward rectifier K⁺ currents, according to the European Heart Journal 2
Contractile dysfunction in AF is characterized by impaired Ca²⁺ handling and altered myofibrillar energetics, as stated by the European Heart Journal 2

Advanced age is a significant risk factor for AF, with a prevalence of 1% in individuals under 60 years and over 8% in those over 80 years, as reported by the Annals of Internal Medicine 3
Obesity and chronic obstructive pulmonary disease (COPD) are common comorbidities in AF patients, found in 25% and 10-15% of patients, respectively, according to the European Heart Journal 2
AF can occur with coronary artery disease (CAD), valvular heart disease, cardiomyopathies, hyperthyroidism, and other metabolic disorders, as well as sleep apnea, according to the European Heart Journal 1, 4, 5

ECG documentation is essential for the diagnosis of AF, showing irregular RR intervals, absence of distinct P waves, and replacement of P waves with fibrillatory waves, as stated by the Journal of the American College of Cardiology 6
Additional testing, including a minimum evaluation of chest radiograph, echocardiogram, thyroid function tests, complete blood count, serum electrolytes, and renal and liver function tests, is necessary for diagnosis, as recommended by the Journal of the American College of Cardiology 7
The American Heart Association and American College of Cardiology recommend obtaining a 12-lead ECG during tachycardia to evaluate stability and diagnose the type of tachycardia, and suggest applying vagal maneuvers or adenosine IV to help in diagnosis and differentiation between types of tachycardias 8

AF can be classified into paroxysmal (self-terminating within 7 days), persistent (continuous AF lasting >7 days), long-standing persistent (continuous AF >12 months), and permanent (when rhythm control strategy is abandoned), as defined by the European Heart Journal 1

First-line agents for rate control include beta-blockers and non-dihydropyridine calcium channel blockers, with a target heart rate of 60-100 bpm at rest, as recommended by the Annals of Internal Medicine 3 and the American College of Cardiology 8
Anticoagulation therapy, including warfarin and direct oral anticoagulants, is essential for stroke prevention in AF patients, with selection based on the CHA₂DS₂-VASc score, as recommended by the Annals of Internal Medicine 3 and the American College of Cardiology 8
Pharmacological cardioversion options include amiodarone, flecainide, propafenone, ibutilide, and dofetilide, as reported by the Annals of Internal Medicine 3

AF is associated with a significantly impaired quality of life compared to healthy controls, as reported by the European Heart Journal 2
Cognitive dysfunction may occur due to asymptomatic embolic events in AF patients, according to the European Heart Journal 2
AF is associated with significant morbidity and mortality, including increased stroke risk (5-fold higher than general population), heart failure (3-fold increased risk), and doubled risk of all-cause mortality, according to the American College of Cardiology 6

Rate control with chronic anticoagulation is the recommended strategy for most AF patients, as stated by the Annals of Internal Medicine 3 and the American College of Cardiology 6
Rhythm control is appropriate when based on patient symptoms, exercise tolerance, patient preference, and hemodynamic instability, although it has not been shown superior to rate control in reducing morbidity and mortality, according to the Annals of Internal Medicine 3
The American College of Cardiology recommends management strategies to reduce the risk of stroke, heart failure, and other complications associated with atrial fibrillation 6